查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197520

醫療器械合同製造市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Medical Device Contract Manufacturing Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 106 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計在 2022 年至 2027 年的預測期內，醫療器械合同製造市場將以 10.5% 的複合年增長率增長。

儘管 COVID-19 大流行造成了中斷，但醫療器械合同製造市場正在復蘇，客戶需求強勁。 這種強勁的增長也反映在外包供應商之間的併購活動中。 根據美國食品和藥物管理局 (US-FDA) 2020 年更新，大流行還引發了對呼吸機、氧氣濃縮器和 COVID-19 相關產品等醫療設備的前所未有的需求。 出於這個原因，通過合同製造公司開發醫療器械的外包活動變得更加活躍。 例如，2020 年 10 月，Relay Medical Co., Ltd. 和 Fio Co., Ltd. 與 FidNet Rapid Response Group 一起收購了總部位於美國的 Fionet 公司獲得 FDA 批准的大流行應對設備，以提供交鑰匙服務和全球覆蓋。它將由 Keytronics 生產，Keytronics 是一家合同製造公司，用於 據報導，該公司最近正在製造與 COVID-19 相關的醫療設備。 此外，根據美國國立衛生研究院 (NIH) 2020 年 10 月的更新，該組織正在與生物醫學高級研究與開發機構 (BARDA) 合作開發一種新的 COVID-19 測試技術，用於擴大和生產一系列測試。我們正在報告 3 輪合同簽署。 因此，上述因素表明 COVID-19 大流行對市場增長產生了積極影響。

此外，醫療器械市場的增長和技術的進步是對市場增長做出重大貢獻的因素。

醫療器械市場的增長是推動市場增長的關鍵因素。 例如，根據 2022 年世界衛生組織 (WHO) 更新，估計有 200 萬種醫療器械被歸入 7000 多個通用器械組。 同樣在 2021 年 6 月，羅馬尼亞 Rosti 贏得了新製造工廠的醫療設備合同。 這表明全球醫療器械市場正在擴大，對合同製造服務的需求不斷增加。 此外，一些公司沒有能力在內部製造醫療設備。 因此，醫療器械合同製造受到青睞，這反過來又推動了市場增長。

為了擴大醫療設備的使用，已經啟動了多項舉措。 例如，2021 年 10 月，印度政府宣布計劃起草新藥品、化妝品和醫療器械法案，以提高全球市場對醫療器械的接受度。 此外，據報導，2021 年 10 月，SpinaFX Medical Inc .與加拿大最大的醫療設備設計、開發和製造服務機構 StarFish Product Engineering Inc .簽訂了商業合同製造協議。

然而，醫療器械市場的整合成為阻礙醫療器械代工市場發展的主要因素。

醫療器械代工市場趨勢

在醫療器械代工市場中，IVD器械板塊有望佔據最大市場份額

按設備劃分，IVD 設備領域預計將佔據很大份額。 這可能是由於新興國家醫院數量的增加、醫療基礎設施的發展、全球體外診斷測試量的增加以及慢性病的高患病率等因素造成的。

體外診斷醫療設備是使用生物樣本進行測試以了解人們健康狀況的設備。 有各種各樣的體外診斷醫療設備，從懷孕的自我診斷和糖尿病患者的血糖測試到臨床實驗室進行的高級診斷。 由於終端用戶的高采用率，IVD 設備正在擴大其在醫療環境中的使用。 對醫療點 (POC) 設備和疾病監測、診斷和預防能力的需求正在推動這一領域的增長。 對個性化、先進和快速診斷設備的需求不斷增長，將推動 IVD 設備的市場增長。

一些市場細分公司正在努力實施戰略舉措，以促進該細分市場的增長。 例如，2021 年 8 月，Tecan 收購了 Paramit，這是一家主要專注於醫療和生命科學設備的全球合同開發和製造公司。 收購 Paramit 有望進一步擴大帝肯在生命科學和體外診斷 (IVD) 解決方案領域的地位。

此外，2021 年 6 月，Somnix 和 Maxnerva Technology Services 就體外診斷 (IVD) 簽訂了合作合同開發和製造組織 (CDMO)。 此外，2021 年 11 月，BioFortuna 是一家體外診斷和即時檢測設備的合同開發和製造公司，將搬遷到北威爾士迪賽德的一個新的最先進的工廠，將其生產規模擴大一倍容量。我被允許。

此外，隨著世界範圍內癌症疾病的增多，對體外診斷的需求越來越大，對體外診斷發展的製造服務需求也越來越大。

因此，由於上述因素，預計市場在預測期內將出現顯著增長。

北美主導市場，預計在預測期內也會如此

在北美，美國占有很大的份額。 推動市場增長的主要因素是醫療保健支出的增加、慢性病的流行以及市場參與者的強大存在。

例如，根據美國疾病控制與預防中心 (CDC) 2022 年 2 月的更新，2020 年有 4.6% 的成年人被診斷出患有冠心病。 此外，根據美國國家癌症研究所 (NCI) 2020 年的統計數據，美國將有大約 1,806,590 例癌症病例，預計到 2030 年癌症倖存者將達到 220 萬。 隨著慢性病負擔的增加，用於診斷和治療的醫療器械的需求正在增加。 因此，對合同製造服務的需求預計會增加。

此外，市場進入者的多項舉措也為市場的增長做出了貢獻。 例如，2021 年 9 月，連接器和傳感器領域的全球領導者 TE Con□□nectivity 將加入 Toolbox Medical Innovations（美國加利福尼亞州卡爾斯巴德），後者為 Point of Care IVD 產品提供開發、可用性測試、臨床研究和製造服務。收購了 3 家專注於微流體試劑盒和吸塑試劑包開發、可用性測試、臨床研究和製造的公司。

因此，由於上述市場發展，預計市場在預測期內將出現顯著增長。

醫療器械代工市場競爭者分析

醫療器械合同製造市場競爭適中，由幾家重要參與者組成。 就市場份額而言，一些主要參與者主導著市場。 此外，一些主要參與者正在積極收購其他公司以鞏固其在全球市場的地位。 目前主導市場的公司包括 Biofortuna Limited、Jabil Inc.、Synecco、Gerresheimer AG 和 Invetech。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 不斷發展的醫療器械市場
    • 技術進步
  • 市場製約因素
    • 醫療器械市場整合
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按設備
    • 體外診斷設備
      • 體外診斷醫療設備
      • 體外診斷醫療器械耗材
    • 診斷成像設備
    • 心髒病學相關產品
    • 藥物輸送設備
      • 注射器
      • 注射筆
      • 其他
    • 內窺鏡設備
    • 眼科設備
    • 骨科設備
    • 牙科設備
    • 其他
  • 按服務
    • 設備開發和製造服務
      • 設備工程服務
      • 流程開發服務
      • 設備製造服務
    • 質量控制服務
      • 檢驗和測試服務
      • 包裝驗證服務
    • 組裝服務
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Jabil Inc.
    • Synecco
    • Gerresheimer AG
    • Celestica Inc.
    • Nordson Corporation
    • Teleflex Incorporated
    • Integer Holdings Corporation
    • Nipro Corporation
    • SteriPack Group Ltd
    • TE Connectivity Ltd
    • Celestica International
    • Nortech Systems, Inc.
    • Invetech
    • Biofortuna Limited

第7章 市場機會與今後動向

簡介目錄
Product Code: 67523

The medical device contract manufacturing market is expected to register a CAGR of 10.5% over the forecast period, 2022-2027.

The contract manufacturing market for medical devices has rebounded with strong demand from customers despite the disruption caused by the COVID-19 pandemic. The strong uptick reflects this in outsourcing providers' merger and acquisition (M&A) activities. Also, as per a 2020 update by the United States Food and Drug Administration (US-FDA), the pandemic triggered an unprecedented demand for medical devices such as ventilators, oxygen concentrators, and COVID-19-related products. Thus, there has been an increase in outsourcing activities for developing medical devices through companies engaged in contract manufacturing. For instance, in October 2020, Relay Medical Corp. and Fio Corporation, together with Fidonet Rapid Response Group, reported that the United States-based would produce its Fionet pandemic response devices with an FDA-approved contract manufacturer, KeyTronic, which offers turnkey services and global reach. The company has reported making COVID-19-related medical devices recently. Also, per an October 2020 update by the National Institutes of Health (NIH), the organization is working in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), reporting the third round of contract awards for scale-up and manufacturing of new COVID-19 testing technologies. Thus, the factors above indicate that the COVID-19 pandemic has positively impacted the market's growth.

Furthermore, the significant factors contributing to the market's growth are the growing medical device market and technological advancements.

The growing medical device market is a significant factor driving the market's growth. For instance, as per the 2022 World Health Organization (WHO) update, there are an estimated 2 million different kinds of medical devices categorized into more than 7000 generic device groups. Also, in June 2021, Rosti Romania secured a new medical device contract for its new manufacturing facility. This indicates the growth in the medical devices market worldwide, which is increasing the demand for contract manufacturing services. Also, some companies do not have in-house capabilities for manufacturing medical devices. As a result, contract manufacturing of such devices is preferred, ultimately boosting the market's growth.

Several initiatives are being launched to expand the use of medical devices. For instance, in October 2021, the Indian government announced plans to draft a new drug, cosmetics, and medical device bill to increase the acceptability of medical devices in the global market. Additionally, in October 2021, SpinaFX Medical Inc. reported signing a commercialization contract manufacturing agreement with StarFish Product Engineering Inc., Canada's largest medical device design, development, and manufacturing services organization.

However, consolidation of the medical device market is a significant factor hindering the medical device contract manufacturing market.

Medical Device Contract Manufacturing Market Trends

IVD Device Segment is Expected to Hold the Largest Market Share in the Medical Device Contract Manufacturing Market

By devices, the IVD devices segment is anticipated to hold a significant share of the market. This can be attributed to factors such as growing numbers of hospitals in developing countries; development of healthcare infrastructure; rising IVD test volume worldwide, and the high prevalence of chronic diseases.

In vitro, diagnostic medical devices are tests used on biological samples to determine the status of a person's health. There is a broad range of in vitro diagnostics (IVDs), from self-tests for pregnancy and blood glucose tests for people with diabetes to sophisticated diagnoses performed in clinical laboratories. The use of IVD devices is increasing in medical facilities as the adoption rate for these devices is higher among end users. The demand for point-of-care devices and their ability to monitor, diagnose, and prevent diseases contribute to the segment's growth. The increased demand for personalized, advanced, and rapid diagnostic devices will boost market growth for IVD devices.

Several market players are engaged in implementing strategic initiatives, thereby contributing to the segment's growth. For instance, in August 2021, Tecan acquired Paramit, global contract development and manufacturing company mainly focused on medical devices and life sciences instruments. The acquisition of Paramit is believed to further expand Tecan's position in solutions for life sciences and in-vitro diagnostics (IVD).

Also, in June 2021, Somnics, Inc. and Maxnerva Technology Services signed a cooperation agreement regarding the contract development and manufacturing organization (CDMO) of in vitro diagnostic devices (IVD). Moreover, in November 2021, Biofortuna, a specialist contract development, and manufacturing partner to the IVD and point-of-care testing sectors, doubled its manufacturing capacity following its relocation to new state-of-the-art facilities in Deeside, North Wales.

Furthermore, with the increasing burden of cancer disorders worldwide, the demand for IVD devices is increasing, complementing the need for manufacturing services for developing in-vitro diagnostic devices.

Thus, the market is expected to witness significant growth over the forecast period due to the abovementioned factors.

North America Dominates the Market and Expected to do Same in the Forecast Period

Within North America, the United States has held a significant share of the market. The major factors fueling the market's growth are the growing expenditure on healthcare, the prevalence of chronic disorders, and the strong presence of market players.

For instance, as per a February 2022 update by the Centers for Disease Control and Prevention (CDC), in 2020, the percentage of adults who have ever been diagnosed with coronary heart disease was 4.6%. Additionally, as per the 2020 statistics by the National Cancer Institute (NCI), about 1,806,590 cases will be diagnosed in the United States in 2020, and the number of cancer survivors is projected to reach 2.2 million by 2030. Such an anticipated increase in the burden of chronic diseases is leading to high demand for medical devices used in diagnosing and treating such conditions. As a result, the need for contract manufacturing services is expected to rise.

Moreover, several initiatives undertaken by the market players contribute to the market's growth. For instance, in September 2021, TE Connectivity, a world leader in connectors and sensors, acquired three companies focused on microfluidic cartridge and blister reagent package development, usability testing, clinical research, and manufacturing, including Toolbox Medical Innovations (Carlsbad, California, USA), which provides development, usability testing, clinical research, and manufacturing services for Point of Care IVD products.

Thus, the market is expected to witness significant growth during the forecast period due to the above developments.

Medical Device Contract Manufacturing Market Competitor Analysis

The medical device contract manufacturing market is moderately competitive and consists of several significant players. In terms of market share, a few major players dominate the market. And some prominent players are vigorously making acquisitions of other companies to consolidate their global market positions. Some companies currently dominating the market are Biofortuna Limited, Jabil Inc., Synecco, Gerresheimer AG, and Invetech.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Medical Device Market
    • 4.2.2 Advancement in Technology
  • 4.3 Market Restraints
    • 4.3.1 Medical Device Market Consolidation
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Device
    • 5.1.1 IVD Devices
      • 5.1.1.1 IVD Equipments
      • 5.1.1.2 IVD Consumables
    • 5.1.2 Diagnostic Imaging Devices
    • 5.1.3 Cardiovascular Devices
    • 5.1.4 Drug Delivery Devices
      • 5.1.4.1 Syringes
      • 5.1.4.2 Pen Injectors
      • 5.1.4.3 Others
    • 5.1.5 Endoscopy Devices
    • 5.1.6 Ophthalmology Devices
    • 5.1.7 Orthopedic Devices
    • 5.1.8 Dental Devices
    • 5.1.9 Other Devices
  • 5.2 By Service
    • 5.2.1 Device Development and Manufacturing Service
      • 5.2.1.1 Device Engineering Service
      • 5.2.1.2 Process Development Service
      • 5.2.1.3 Device Manufacturing Service
    • 5.2.2 Quality Management Service
      • 5.2.2.1 Inspection & Testing Service
      • 5.2.2.2 Packaging Validation Service
    • 5.2.3 Assembly Service
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Jabil Inc.
    • 6.1.2 Synecco
    • 6.1.3 Gerresheimer AG
    • 6.1.4 Celestica Inc.
    • 6.1.5 Nordson Corporation
    • 6.1.6 Teleflex Incorporated
    • 6.1.7 Integer Holdings Corporation
    • 6.1.8 Nipro Corporation
    • 6.1.9 SteriPack Group Ltd
    • 6.1.10 TE Connectivity Ltd
    • 6.1.11 Celestica International
    • 6.1.12 Nortech Systems, Inc.
    • 6.1.13 Invetech
    • 6.1.14 Biofortuna Limited

7 MARKET OPPORTUNITIES AND FUTURE TRENDS